Data protection Impressum

Biotech

The Foundation for Technological Innovation (FIT) has awarded funding to promising Western Switzerland start-ups PeriVision, Bioscibex, and Carewell, to accelerate their development in healthtech and biotechnology.

Western Switzerland innovators PeriVision, Bioscibex and Carewell receive support from FIT

17 March 2025

Lausanne-based Limula has introduced LimONE, a fully automated cell therapy manufacturing platform designed to streamline production, reduce costs, and improve accessibility for patients. The company expects to deliver the first units by 2028.

Limula unveils LimONE, a breakthrough in automated cell therapy manufacturing

10 March 2025

Geneva has unveiled its new Innovation Master Plan 2025-2027 (“Plan Directeur de l’Innovation 2025-2027” in French), designed to consolidate the canton’s position as a leading international innovation hub. Backed by CHF 11 million in public investment, the strategy focuses on infrastructure enhancement, targeted financing, and fostering entrepreneurship to bolster Geneva’s economic strength.

Geneva strengthens its innovation ecosystem with a strategic development plan

10 March 2025

Bernese start-up ATANIS Biotech has won Phase 2 of the FARE Innovation Award Diagnostic Challenge, securing USD 2 million to advance its FAST-PASE allergy test.

ATANIS Biotech secures USD 2 million for its FAST-PASE allergy test

3 March 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (February 2025)

25 February 2025

Vaud-based biopharma Oculis has successfully completed an oversubscribed USD 100 million offering, further strengthening its pipeline of innovative ophthalmic and neuro-ophthalmic treatments.

Oculis secures USD 100 million to advance its neuroprotective treatment pipeline

17 February 2025

The Deep Tech Nation Switzerland Foundation and the Startupticker Foundation have launched the Deep Tech Nation Information Platform, a central resource aimed at enhancing venture capital investment in Swiss deep tech start-ups.

Launch of the Swiss Deep Tech Information Platform

10 February 2025

Biotech company CELLnTEC is playing a key role in the NEOLIVER project, a European-Swiss initiative developing the world’s first autologous bioprinted liver for clinical use. The project, co-funded by the EU and the Swiss government, aims to address the global organ donor shortage through innovative bioprinting technologies.

Bern-based CELLnTEC joins NEOLIVER project to develop bioprinted liver constructs

10 February 2025

Swiss start-ups raised CHF 2.4 billion in venture capital in 2024, marking an 8.5% decline from the previous year. The number of financing rounds also fell for the first time, reflecting a challenging investment climate. Despite these setbacks, biotech and cleantech sectors saw strong growth, and investor sentiment remains optimistic for 2025.

Swiss start-ups secure CHF 2.4 billion in 2024 amid shifting investment trends

4 February 2025

The Swiss Institute of Bioinformatics has inaugurated the Centre for Pathogen Bioinformatics in Bern, a state-of-the-art facility dedicated to strengthening genomic surveillance of infectious diseases.

The Centre for Pathogen Bioinformatics was inaugurated in Bern

4 February 2025

1 2 3 4 5 … 19